• Evolving Perspectives on HR-Positive Metastatic Breast Cancer: Current Understanding and New Insights
    May 21 2024

    Are you up to date on the latest developments in hormone receptor-positive metastatic breast cancer? Listen to our expert panel to find out more!

    Credit available for this activity expires: 05/20/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000713?ecd=bdc_podcast_libsyn_mscpedu

    Show more Show less
    35 mins
  • SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question
    May 13 2024

    Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)?

    Credit available for this activity expires: 5/13/2024
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu

    Show more Show less
    28 mins
  • Personalizing Care for Breast Cancer: The Precision Medicine Approach
    Apr 30 2024

    Do you really know the optimal biomarker tests for personalizing breast cancer treatment? Are some just unnecessary? Find out from the experts!

    Credit available for this activity expires: 4/30/2025
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000564?ecd=bdc_podcast_libsyn_mscpedu

    Show more Show less
    35 mins
  • A Roadmap to Relief: Managing Agitation in Dementia Associated With Alzheimer's Disease
    Apr 29 2024

    Do you know the symptoms that affect more than 80% of people with Alzheimer's disease in some countries?

    Credit available for this activity expires: 04/29/2025
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000723?ecd=bdc_podcast_libsyn_mscpedu

    Show more Show less
    1 hr
  • Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow
    Apr 26 2024

    Are you selecting the right Bruton tyrosine kinase (BTK) inhibitor for your patients with chronic lymphocytic leukemia (CLL)? Experts discuss the key differentiators and upcoming developments in the field.

    Credit available for this activity expires: 04/26/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000717?ecd=bdc_podcast_libsyn_mscpedu

    Show more Show less
    38 mins
  • How I Treat Alagille Syndrome
    Apr 22 2024

    Are you looking for practical advice on using ileal bile acid transporter (IBAT) inhibitors in clinical practice?

    Credit available for this activity expires: 4/16/2024
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000397?ecd=bdc_podcast_libsyn_mscpedu

    Show more Show less
    36 mins
  • Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care?
    Mar 29 2024

    How much do you know about future treatment options for type 2 diabetes (T2D)? Join Drs Vilsbøll and Nauck to find out.

    Credit available for this activity expires: 03/27/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000462
    ?ecd=bdc_podcast_libsyn_mscpedu

    Show more Show less
    21 mins
  • Connecting the Clinical Clues of Alagille Syndrome
    Mar 27 2024

    Do you know the key features of Alagille syndrome and how therapies that target the bile acid cycle can improve clinical symptoms?

    Credit available for this activity expires: 3/26/2025
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000514?ecd=bdc_podcast_libsyn_mscpedu

    Show more Show less
    28 mins